Sexual Risks in Prep Users (PREP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03975517|
Recruitment Status : Recruiting
First Posted : June 5, 2019
Last Update Posted : August 20, 2019
Primary purpose of the study: to describe sexual behavior of Prep users, whatever mode of intake, ie continuous or on-demand; it has been shown in some studies, an increase of sexual risks in Prep users, and therefore an similar increase of STIs (sexually transmitted diseases); using a self-questionnaire, we'd like to evaluate sexual behavior before, and 6 months after, starting Prep.
Secondary purposes: to describe medical characteristics of Prep users (past medical condition, demographic characteristics, vaccinations, kidney function, serological results, urine and anal/pharyngeal swabs), clinical and biological Prep safety, STIs occurrence, and antibiotic prescriptions, continuous or on-demand intake, Prep indication.
|Condition or disease||Intervention/treatment|
|HIV Infection Prep Prescription Vaccinations Sexually Transmitted Diseases||Behavioral: PrEP|
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Analysis of Sexual Risks in Prep (Pre-exposure Prophylaxis) Users Followed-up in a University Care Centre (Le Trait d'Union)|
|Actual Study Start Date :||June 4, 2019|
|Actual Primary Completion Date :||June 4, 2019|
|Estimated Study Completion Date :||June 2021|
- Behavioral: PrEP
Define the behavioral characteristics of the active file of patients using PrEP in Strasbourg in 2019.
- Analysis of sexual behavior in Prep users [ Time Frame: 6 months ]Sexual behavior will be evaluated with a questionnaire
- Description of the medical profile of the Strasbourgeoise active file [ Time Frame: 6 months ]Describe the active line of people using Prep and followed in the center
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03975517
|Contact: David REY||+33 22.214.171.124.51||David.firstname.lastname@example.org|
|Les Hôpitaux Universitaires de Strasbourg||Recruiting|
|Strasbourg, France, 67091|
|Contact: David REY +33 126.96.36.199.51 David.email@example.com|
|Principal Investigator: David REY|
|Sub-Investigator: Marie-Laure BATARD|
|Sub-Investigator: Christine CHENEAU|
|Principal Investigator:||David REY||Hôpitaux Universitaires de Strasbourg|